Qilu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DECITABINE, with a corresponding US DMF Number 29749.
Remarkably, this DMF maintains an Active status since its submission on September 25, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 17, 2016, and payment made on September 25, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II